Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Unknown 10Completed 5Recruiting 4Not yet recruiting 2Active not recruiting 2Withdrawn 1Terminated 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Rectal Neoplasms 2Colorectal Neoplasms 1

Interventions

Capecitabine 13Fluorouracil 12Oxaliplatin 9Nivolumab 9Radiotherapy 8Leucovorin 8Cetuximab 8Magnetic Resonance Spectroscopy 6Irinotecan 5pembrolizumab 4encorafenib 4Surgical Procedures, Operative 4Sigmoidoscopy 4Radiotherapy, Intensity-Modulated 4Surveys and Questionnaires 3Standard of Care 3Specimen Handling 3Biopsy 3Bevacizumab 3dostarlimab 2dehydroftorafur 2atezolizumab 2XELOX 2X-Rays 2Observation 2Magnetic Resonance Imaging 2Immunoglobulin G 2Folfox protocol 2Drug Therapy 2Disulfides 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × Rectal Neoplasms × XELOX × Clear all
NCT07127497 2025-11-21

Clinical Study on the Safety and Relationship of Sintilimab Combined With Chemotherapy in Neoadjuvant Treatment of Locally Advanced Rectal Adenocarcinoma

The First Affiliated Hospital of Anhui Medical University

Phase 2 Active not recruiting
50 enrolled
Gastrointestinal

Rectal Neoplasms

NCT03840239 2023-10-25

TESS

Sun Yat-sen University

Phase 2 Active not recruiting
98 enrolled
Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡